The Hypothalamus and β-Cell Connection in the Gene-Targeting Era

被引：13
|
作者：
Schwartz, Michael W. [1 ]
Guyenet, Stephan J.
Cirulli, Vincenzo
机构：
[1] Univ Washington, Sch Med, Dept Med, Div Endocrinol Metab & Nutr, Seattle, WA 98195 USA
来源：
DIABETES | 2010年 / 59卷 / 12期
关键词：
SITE-SPECIFIC RECOMBINATION; CRE-RECOMBINASE; INSULIN; MOUSE; MICE; DIFFERENTIATION; EXPRESSION; LINEAGES; ISLETS; GROWTH;
D O I：
10.2337/db10-1149
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2991 / 2993
页数：3
相关论文
共 50 条
  • [1] Gene-targeting in Drosophila validated
    Gloor, GB
    TRENDS IN GENETICS, 2001, 17 (10) : 549 - 551
  • [2] Advanced Transgenic and Gene-Targeting Approaches
    Xiang Gao
    April Kemper
    Brian Popko
    Neurochemical Research, 1999, 24 : 1181 - 1188
  • [3] Gene-targeting pharmaceuticals for single-gene disorders
    Beaudet, Arthur L.
    Meng, Linyan
    HUMAN MOLECULAR GENETICS, 2016, 25 : R18 - R26
  • [4] Nucleic acids as gene-targeting therapeutics
    Opalinska, JB
    Shetzline, SE
    NUCLEIC ACID THERAPEUTICS IN CANCER, 2004, : 167 - 176
  • [5] Advanced transgenic and gene-targeting approaches
    Gao, X
    Kemper, A
    Popko, B
    NEUROCHEMICAL RESEARCH, 1999, 24 (09) : 1181 - 1188
  • [6] Conditional Gene-Targeting in Mice: Problems and Solutions
    Becher, Burkhard
    Waisman, Ari
    Lu, Li-Fan
    IMMUNITY, 2018, 48 (05) : 835 - 836
  • [7] Gene-targeting technologies for the study of neurological disorders
    Beglopoulos, V
    Shen, J
    NEUROMOLECULAR MEDICINE, 2004, 6 (01) : 13 - 30
  • [8] Gene-targeting technologies for the study of neurological disorders
    Vassilios Beglopoulos
    Jie Shen
    NeuroMolecular Medicine, 2004, 6 : 13 - 30
  • [9] Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines
    Wassef, M.
    Luscan, A.
    Battistella, A.
    Le Corre, S.
    Li, H.
    Wallace, M. R.
    Vidaud, M.
    Margueron, R.
    METHODS, 2017, 121 : 45 - 54
  • [10] Towards 100% gene-targeting efficiency in human cells
    Adachi, N.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1487 - 1487
12345